Systematic review finds extracellular vesicles may modulate inflammation and support cartilage repair in osteoarthritis.
This systematic review examined how extracellular vesicles (EVs)—small membrane-enclosed particles carrying cellular cargo—influence osteoarthritis pathology and potential treatment. The authors describe a "pathological EV cycle" in which EVs from inflammatory cells drive cartilage degradation and bone remodeling, while EVs from therapeutic cells like mesenchymal stromal cells may suppress inflammation and promote tissue repair. The review identifies engineering improvements in EV delivery and potency but notes significant limitations in translating this approach to clinical use.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 3, 2026 · Discovered: Sep 18, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Systematic review
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- Frontiers in Immunology
- Published
- Sep 3, 2026
Sources
Primary source
- Frontiers in immunology ↗Peer reviewed
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.